Pharma Contract Manufacturers
Sai Life hits record high in weak market; rebounds 5% from day's low
Supported by solid demand, disciplined execution, and capex programs progressing as planned, Sai Life management remains confident in sustaining positive growth momentum.
 "Sai Life hits record high in weak market; rebounds 5% from day's low")
Laurus Labs soars 8% in 2 days, nears record high; analysts see more upside
The management expects better Q4 and a decent overall growth in FY27
 "Laurus Labs soars 8% in 2 days, nears record high; analysts see more upside")
Sai Life rallies 5%, hits all-time high; what's driving pharma stock?
In H1FY26, total revenue of the Sai Life Sciences increased by 53% YoY at ₹1,034 crore, driven by healthy growth across both the CRO and the CDMO business.
 "Sai Life rallies 5%, hits all-time high; what's driving pharma stock?")
Laurus Labs soars 6% in 2 days, market cap tops ₹ 50,000 crore; here's why
At 11:29 AM, Laurus Labs' stock was quoting 2 per cent higher at ₹943.15 on the BSE, commanding an m-cap of ₹50,913 crore, exchange data shows
 "Laurus Labs soars 6% in 2 days, market cap tops ₹ 50,000 crore; here's why")
Small contract manufacturers wait to take a shot at Covid vaccines
A host of lesser-known vaccine makers are eyeing contract manufacturing opportunities for global and domestic majors
 "Small contract manufacturers wait to take a shot at Covid vaccines")
Pharma contract manufacturers hit as IPM slows down
Contract manufacturers claim that at least 40-60% of pharmaceutical manufacturing in the country is outsourced by big pharma
 "Pharma contract manufacturers hit as IPM slows down")